# Remifentanil and Midazolam on Propofol for Loss of Consciousness

> **NCT02536690** · NA · COMPLETED · sponsor: **Severance Hospital** · enrollment: 120 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Propofol
- **DRUG:** Remifentanil
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT02536690
- **Lead sponsor:** Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02536690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02536690, "Remifentanil and Midazolam on Propofol for Loss of Consciousness". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02536690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*